Sources: FactSet, Tullett PrebonĬommodities & Futures: Futures prices are delayed at least 10 minutes as per exchange requirements. Sources: FactSet, Tullett PrebonĬurrencies: Currency quotes are updated in real-time. Sources: FactSet, Dow Jonesīonds: Bond quotes are updated in real-time.
Sources: FactSet, Dow JonesĮTF Movers: Includes ETFs & ETNs with volume of at least 50,000. Stock Movers: Gainers, decliners and most actives market activity tables are a combination of NYSE, Nasdaq, NYSE American and NYSE Arca listings. Overview page represent trading in all U.S. Indexes: Index quotes may be real-time or delayed as per exchange requirements refer to time stamps for information on any delays.
Copyright 2019© FactSet Research Systems Inc. Fundamental company data and analyst estimates provided by FactSet. International stock quotes are delayed as per exchange requirements. stock quotes reflect trades reported through Nasdaq only comprehensive quotes and volume reflect trading in all markets and are delayed at least 15 minutes. Dividend Yield A company's dividend expressed as a percentage of its current stock price. Restricted stock typically is that issued to company insiders with limits on when it may be traded. To calculate, start with total shares outstanding and subtract the number of restricted shares. Public Float The number of shares in the hands of public investors and available to trade. Shares Outstanding Number of shares that are currently held by investors, including restricted shares owned by the company's officers and insiders as well as those held by the public. For companies with multiple common share classes, market capitalization includes both classes. Market Cap is calculated by multiplying the number of shares outstanding by the stock's price. Market Capitalization Reflects the total market value of a company. Earnings Per Share (TTM) A company's net income for the trailing twelve month period expressed as a dollar amount per fully diluted shares outstanding. The Company’s lead product, an investigational new drug called Ampligen ® (rintatolimod) is an immuno-modulator with broad spectrum activity being investigated for globally important cancers, viral diseases and disorders of the immune system.įor more information, please visit and connect with the Company on Twitter, LinkedIn, and Facebook.P/E Ratio (TTM) The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations for the trailing 12 month period. is an immuno-pharma company focused on the research and development of therapeutics to treat multiple types of cancers, immune disorders, and viral diseases, including COVID-19. The live webcast will be accessible on the Events and Presentations page of the Investors section of the Company’s website,, and will be archived for 90 days following the live event.ĪIM ImmunoTech Inc. Interested participants and investors may access the conference call by dialing (877) 407-9219 (domestic) or (201) 689-8852 (international) and referencing the AIM ImmunoTech Conference Call. Equels, Chief Executive Officer and Christopher McAleer, PhD, Scientific Officer. The call will be hosted by members of AIM’s leadership team, Thomas K. AIM ImmunoTech management will host its inaugural quarterly conference call and live audio webcast to discuss the operational and financial results on Monday, April 3 rd at 8:30 AM ET.
AIM IMMUNOTECH FULL
(NYSE American: AIM) (“AIM” or the “Company”), an immuno-pharma company focused on the research and development of therapeutics to treat multiple types of cancers, immune disorders, and viral diseases - including COVID-19, the disease caused by the SARS-CoV-2 virus - today announced that it will report its financial results for the full year Decemafter market close on Friday, March 31, 2023. OCALA, Fla., Ma(GLOBE NEWSWIRE) - AIM ImmunoTech Inc.
0 kommentar(er)
